Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetes Care

• Publication date

  1998-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.21.4.487PMID 9571329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• E-Selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress

  1997cited by this paper
• Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL.

  1997cited by this paper
• The Mystery of Diabetes and Atherosclerosis: Time for a New Plot

  1997cited by this paper
• Multiple growth factors are associated with lesions of atherosclerosis: Specificity or redundancy?

  1996cited by this paper
• Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL

  1996cited by this paper
• Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.

  1996cited by this paper
• High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress

  1996cited by this paper
• Human monocytes/macrophages release TNF-alpha in response to Ox-LDL.

  1996cited by this paper
• Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM

  1996cited by this paper
• Cytokine production pathway in the elderly

  1996cited by this paper
• Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control

  1995cited by this paper
• Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b.

  1995cited by this paper
• Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.

  1995cited by this paper
• [Respiratory burst of neutrophils and cytokine profile in the non-insulin-dependent diabetic].

  1995cited by this paper
• Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis.

  1994cited by this paper
• Detection of serum IL-6 in patients with diabetic nephropathy.

  1994cited by this paper
• Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL.

  1994cited by this paper
• Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.

  1994cited by this paper
• The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human Monocytes

  1994cited by this paper
• Increased Levels of Soluble Adhesion Molecules in Type 2 (Non-Insulin Dependent) Diabetes mellitus Are Independent of Glycaemic Control

  1994cited by this paper
• Long-term complications of diabetes mellitus.

  1993cited by this paper
• Circulating adhesion molecules in disease.

  1993cited by this paper
• In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.

  1992cited by this paper
• Lipoprotein Oxidation and Lipoprotein-lnduced Cell Injury in Diabetes

  1992cited by this paper
• Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment.

  1992cited by this paper
• Molecular mechanism of blood monocyte adhesion to vascular endothelial cells.

  1992cited by this paper
• Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats.

  1992cited by this paper
• Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo.

  1992cited by this paper
• Gliclazide: a general free radical scavenger.

  1991cited by this paper
• The effect of Diamicron on the secretion and action of insulin.

  1991cited by this paper
• Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

  1990cited by this paper
• Role of oxidatively modified LDL in atherosclerosis.

  1990cited by this paper
• Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages.

  1990cited by this paper
• Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• [Long-term complications in diabetes mellitus].

  1989cited by this paper
• Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.

  1988cited by this paper
• Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation.

  1987cited by this paper
• Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor.

  1987cited by this paper
• Inducible Endothelial Functions in Inflammation and Coagulation

  1987cited by this paper
• Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes.

  1987cited by this paper
• Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

  1987cited by this paper
• Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

  1985cited by this paper
• Neutrophil and monocyte adherence in diabetes mellitus, alcoholic cirrhosis, uraemia and elderly patients.

  1985cited by this paper
• Free malonaldehyde determination in tissues by high-performance liquid chromatography.

  1984cited by this paper
• Lipid peroxide level in plasma of diabetic patients.

  1979cited by this paper
• Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

  1978cited by this paper
• Practical methods for plasma lipoprotein analysis.

  1968cited by this paper
• Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

  1968cited by this paper

• The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus

  2024cites this paper
• Gliclazide Reduces Colitis-Associated Colorectal Cancer Formation by Deceasing Colonic Inflammation and Regulating AMPK-NF-κB Signaling Pathway

  2023cites this paper
• Meta-Analysis and Network Analysis Differentially Detect Various Pro-Inflammatory Mediators and Risk Factors for Type 2 Diabetes in the Elderly

  2023cites this paper
• Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases.

  2023cites this paper
• Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis

  2021cites this paper
• Glucose metabolism in cancer: heterogeneity and potentials for targeting in patients

  2021cites this paper
• Sulfonylurea derivatives and cancer, friend or foe?

  2019cites this paper
• Synergistic action of ursolic acid and metformin in experimental model of insulin resistance and related behavioral alterations

  2018cites this paper
• Regulation of MMP 2 and MMP 9 expressions modulated by AP-1 (c-jun) in wound healing: improving role of Lucilia sericata in diabetic rats

  2018cites this paper
• The role of FGF21 in regulating energy homeostasis

  2017cites this paper
• Fish oil emulsion supplementation might improve quality of life of diabetic patients due to its antioxidant and anti-inflammatory properties.

  2017cites this paper
• Serum concentrations and renal expressions of IL-1 and TNF-a early after hemorrhage in rats under the effect of glibenclamide.

  2016cites this paper
• Tumor necrosis factor-α, interleukin-4 and -6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus

  2016cites this paper
• Bone Marrow Stem Cells and Bone Turnover in Diabetic Disease

  2016cites this paper
• The hypoglycemic risk of glyburide (glibenclamide) compared with modified-release gliclazide.

  2015cites this paper
• Comparison of Conventional Inflammatory Parameters with Tumor Necrosis Factor- α Levels in Different Stages of Diabetic Retinopathy and Non-Diabetic Controls -

  2015cites this paper
• The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.

  2015cites this paper
• SENSITIVITY AND GLUCOSE HOMEOSTASIS HAVE A BENEFICIAL ROLE IN INSULIN COUNTERPOINT: INTERLEUKIN-6 DOES NOT

  2015cites this paper
• Oxidative Stress and Complications of the Diabetic Foot

  2014cites this paper
• Comparative study on the effect of antioxidants &agr;-lipoic acid and N-acetyl cysteine on the structure of the renal tubules of diabetic rabbits

  2014cites this paper
• Ocular Inflammation in Uveal Tract in Aged Obese Type 2 Diabetic Rats (Spontaneously Diabetic Torii Fatty Rats)

  2014cites this paper
• Type-2 diabetes mellitus, metabolic control, serum inflammatory factors, lifestyle, and periodontal status

  2014cites this paper
• The Effect of Pioglitazone on Antioxidant Levels and Renal Histopathology in Streptozotocin-Induced Diabetic Rats

  2013cites this paper
• A Review on the Formulation and Analysis of Anti-Diabetic Agent: Gliclazide

  2013cites this paper
• The development and characterisation of a murine model of type 2 diabetes and burkholderia pseudomallei infection

  2013cites this paper
• Variations in tissue selectivity amongst insulin secretagogues: a systematic review

  2012cites this paper
• Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axis.

  2012cites this paper
• Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.

  2011cites this paper
• Oxidative stress in type 2 diabetes mellitus and methods for its correction

  2011cites this paper
• Evaluation of chylomicron effect on ASP production in 3T3-L1 adipocytes.

  2011cites this paper
• Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion

  2011cites this paper
• Differential regulation of TLR4 expression in human B cells and monocytes.

  2010cites this paper
• Diabetes is a proinflammatory state: a translational perspective

  2010cites this paper
• CD14＋monocytes are vulnerable and functionally impaired under ER stress in patients with type 2 diabetes

  2010influential citation
• PARTICULARITES DE L'ATHEROSCLEROSE DU SUJET NON DIABETIQUE, DIABETIQUE DE TYPE 2, ET/OU STEATOSIQUE NON ALCOOLIQUE: DE LA PHYSIOPATHOLOGIE AUX TECHNIQUES D'IMAGERIE NON INVASIVES

  2010cites this paper
• The effect of Porphyromonas gingivalis infection on cytokine levels in type 2 diabetic mice.

  2009cites this paper
• CD 14 + monocytes are vulnerable and functionally impaired under ER stress in patients with type 2 diabetes

  2009influential citation
• CD14+ Monocytes Are Vulnerable and Functionally Impaired Under Endoplasmic Reticulum Stress in Patients With Type 2 Diabetes

  2009cites this paper
• Evaluation of gliclazide ability to attenuate the hyperglycaemic ‘memory’ induced by high glucose in isolated human endothelial cells

  2008cites this paper
• The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus

  2008cites this paper
• The Role of Obesity in Insulin Resistance

  2008cites this paper
• Cytokine Secretion in Long-standing Diabetes Mellitus Type 1 and 2: Associations with Low-grade Systemic Inflammation

  2008cites this paper
• Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.

  2008cites this paper
• Obesity, inflammation, and insulin resistance.

  2007cites this paper
• Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.

  2007cites this paper
• Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).

  2007cites this paper
• Effect of Luzindole and Other Melatonin Receptor Antagonists on Iron‐ and Lipopolysaccharide‐Induced Lipid Peroxidation in Vitro

  2007cites this paper
• Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective.

  2007cites this paper
• Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications.

  2007cites this paper
• Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis.

  2007cites this paper
• Sulfatide increases adiponectin and decreases TNF-alpha, IL-6, and IL-8 in human adipose tissue in vitro.

  2007cites this paper
• Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis.

  2007cites this paper
• COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS

  2007cites this paper
• Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.

  2006influential citation
• Effect of gliclazide modified release on adiponectin, interleukin‐6, and tumor necrosis factor‐α plasma levels in individuals with type 2 diabetes mellitus

  2006cites this paper
• Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients.

  2006cites this paper
• Double‐blind, randomized, multicentre study of the efficacy and safety of gliclazide‐modified release in the treatment of Chinese type 2 diabetic patients

  2006cites this paper
• Gliclazide inhibits differentiation-associated biologic events in human monocyte-derived macrophages.

  2006cites this paper
• Effects of gliclazide beyond metabolic control.

  2006cites this paper
• Interrelationship of Matrix Metalloproteinase and TNF-α in Human Gingiva with Chronic Periodontitis associated to Type 2 Diabetes Mellitus

  2006cites this paper
• Chapter 8 – Diabetes and Inflammation

  2006cites this paper
• Effects on immune response of antidiabetic ingredients from white-skinned sweet potato (Ipomoea batatas L.).

  2005cites this paper
• Basic nutritional investigation Effects on immune response of antidiabetic ingredients from white- skinned sweet potato (Ipomoea batatas L.)

  2005cites this paper
• Glucose Intolerance Modifies the Inflammatory Response After Intestinal Ischemia-Reperfusion

  2005cites this paper
• p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis*

  2005cites this paper
• Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.

  2005cites this paper
• Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.

  2005cites this paper
• Gliclazide Attenuates the Intracellular Ca2+ Changes Induced In Vitro by Ischemia in the Retinal Slices of Rats with Streptozotocin-Induced Diabetes

  2005cites this paper
• Secondary sulfonylurea failure: comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide.

  2005cites this paper
• Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes.

  2004cites this paper
• In vitro mononuclear cell production of tumour necrosis factor-alpha and weight loss.

  2004cites this paper
• In vitro mononuclear cell production of tumour necrosis factor-α and weight loss

  2004cites this paper
• HOT TOPIC Adipocytokines and Insulin Resistance

  2004cites this paper
• Adipocytokines and insulin resistance.

  2004cites this paper
• Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines

  2004cites this paper
• Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation.

  2004cites this paper
• Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease.

  2004cites this paper
• Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes.

  2003cites this paper
• Gliclazide and Diabetic Angiopathy

  2003cites this paper
• Role of pro‐atherogenic adhesion molecules and inflammatory cytokines in patients with coronary artery disease and diabetes mellitus type 2

  2003cites this paper
• Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.

  2003cites this paper
• Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium.

  2003cites this paper
• Bedeutung des Interzellulären Adhäsionsmoleküls-1 (ICAM-1) für die Entwicklung des Diabetes mellitus Typ 1

  2003cites this paper
• Effect of enoxaparin on high glucose-induced activation of endothelial cells.

  2003cites this paper
• Critical review of acylation-stimulating protein physiology in humans and rodents.

  2003cites this paper
• Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects.

  2003cites this paper
• Elevated matrix metalloproteinase‐2 and ‐3 production from human diabetic dermal fibroblasts

  2003cites this paper
• Cytokine signatures in atherosclerotic claudicants.

  2003cites this paper
• PROLONGED SULFONYLUREA TREATMENT HAS NO EFFECT ON LYMPHOCYTE PC-1 EXPRESSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

  2003cites this paper
• Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients.

  2003cites this paper
• Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.

  2003cites this paper
• Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging.

  2003cites this paper
• Thiazolidinediones in the treatment of Type 2 diabetes

  2002cites this paper
• Gliclazide-induced acute hepatitis with hypersensitivity features.

  2002cites this paper
• CASE REPORT: Gliclazide-Induced Acute Hepatitis with Hypersensitivity Features

  2002cites this paper
• Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and Type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency.

  2002cites this paper
• Antioxidant effects of gliclazide, glibenclamide, and metformin in patients with type 2 diabetes mellitus

  2002cites this paper
• Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide

  2002influential citation
• Modificación de los mediadores inflamatorios en isquemia-reperfusión intestinal en un modelo de diabetes tipo 2

  2002cites this paper
• Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse.

  2002cites this paper